RE:RE:Someone liked what they heard today.at the conference........
MILTON, ONTARIO--(Marketwired - April 2, 2015) - Tribute Pharmaceuticals Canada Inc. ("Tribute" or the "Company") (TSX VENTURE:TRX) (OTCQX:TBUFF), a specialty pharmaceutical company with a primary focus on the acquisition, licensing, development and promotion of healthcare products in Canada and the U.S., today announced that Mr. Rob Harris, its President and Chief Executive Officer will participate in a Specialty Pharmaceutical Healthcare Panel Discussion to be held on Thursday, April 9, 2015 at 1:35 PM ET at the Laurentian Bank Securities 2nd Annual Investor Conference in Montreal. Mr. Scott Langille, Tribute's Chief Financial Officer will also attend the conference.
Read more at https://www.stockhouse.com/news/press-releases/2015/04/02/tribute-pharmaceuticals-to-participate-at-laurentian-bank-securities-annual#gcvtb2FT61pBQC8t.99